Efficacy and Safety, Long-Term Study of NPC-16 to Treat Dysmenorrhea

Last updated: April 14, 2019
Sponsor: Nobelpharma
Overall Status: Completed

Phase

3

Condition

Female Hormonal Deficiencies/abnormalities

Menstrual Disorders

Severe Premenstrual Symptom

Treatment

N/A

Clinical Study ID

NCT02362711
NPC-16-2
  • Ages > 16
  • Female

Study Summary

The purpose of this long-term study is to determine whether NPC-16 is effective in the treatment of dysmenorrhea.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • dysmenorrhea

Exclusion

Exclusion Criteria:

  • severe hepatopathy

  • pregnant woman

Study Design

Total Participants: 248
Study Start date:
February 01, 2015
Estimated Completion Date:
January 28, 2017